Global X-Ray Detectors Market to Surpass USD 4.5 Billion Due to Increasing Use of CT Scans for COVID-19 Diagnosis
|
By LabMedica International staff writers Posted on 19 Oct 2021 |

The global X-ray detectors market is projected to expand at a CAGR of 5.9% during the forecast period of 2021-2031 to reach USD 4.6 billion by 2031, driven mainly by the rising use of radiographic chest scans for COVID-19 diagnosis.
These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider. The market growth will be further aided by the increasing use of X-ray detectors in several applications, growing incidences of gastrointestinal, cardiovascular, oral, and genitourinary disorders and introduction of innovative X-ray detectors for security, industrial, medical, dental, veterinary, and other purposes. In addition, technological advancements that will enable detectors to provide better detail, higher resolution, and decreased exposure will also provide a boost to the global X-ray detectors market.
The use of X-ray detectors for COVID-19 diagnosis will prove to be a key contributor to market growth. Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests are accurate in detecting COVID-19 in individuals, but are very complicated, time-consuming, and costly. Stakeholders in the X-ray detectors market are taking advantage of this opportunity to increase the availability of radiological examination through X-ray such as CT (Computed Tomography) scans, which is a cost-efficient and easily available option. The rising use of X-ray detectors for radiographic chest scans during the COVID-19 pandemic offers substantial growth opportunities.
These detectors are also being optimized by the players for various industrial inspection and material sorting applications. In addition, wider application of X-ray detectors in image-guided radiation therapy, fluoroscopy, digital radiography, cone beam CT, digital tomosynthesis, and others are expected to further fuel market growth. The growing focus of several countries on developing a well-established healthcare infrastructure is also likely to drive the growth of the global X-ray detectors market.
Flat panel detectors are expected to observe a rise in demand, as they offer various advantages such as uniform imaging quality, less image distortion, low time consumption, good reproducibility, and better patient condition access, among others. In addition, they are proven to be very successful in high exposure interventional procedures. Among panel types, the large panel category of the X-ray detectors market is expected to witness promising growth. The growing number of patients undergoing diagnostic imaging tests, and expanding adoption of new and advanced large panel detectors are likely to propel the growth of the X-ray detectors market.
Geographically, North America held the largest share of the global X-ray detectors market in 2020 and is expected to maintain its position during the forecast period. The growing number of dental CBCT scans in the US due to increasing dental diseases among a considerable share of its population is anticipated to propel the growth of the North American X-ray detectors market. Furthermore, the Asia Pacific X-ray detectors market is also projected to grow rapidly during the forecast period. Increasing efforts by several countries in the region to develop a well-established healthcare infrastructure, coupled with novel product launches in China and Japan, are expected to fuel the growth of the X-ray detectors market in the Asia Pacific.
Related Links:
Transparency Market Research
Latest COVID-19 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








